The management and outcome of Bacillus Calmette–Guérin vaccine overdose

The management and outcome of Bacillus Calmette–Guérin vaccine overdose

Saved in:

Bibliographic Details
Main Authors:	Sung-Hsi Wei, Wen-Chao Ho, Yi-Ting Chen, Shao-Hui Tsai
Format:	Article
Language:	English
Published:	Elsevier 2018-04-01
Series:	Pediatrics and Neonatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1875957216302169
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bacillus calmette–Guérin scar inflammation after COVID vaccination
by: B N Shiva Prasad
Published: (2022-01-01)

Saudi urologists’ treatment pattern for high-risk Bacillus Calmette–Guérin naïve and Bacillus Calmette–Guérin unresponsive nonmuscle invasive bladder cancer
by: Mohammad Alghafees, et al.
Published: (2025-01-01)

Reaction at the Bacillus Calmette–Guérin Inoculation Site in Patients with Kawasaki Disease
by: Chi-Chieh Lai, et al.
Published: (2013-02-01)

Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023
by: Jiwoong Yu, et al.
Published: (2023-11-01)

Pneumonitis secondary to intravesical Bacillus-Calmette-Guérin (BCG) immunotherapy
by: Komeil Alattar, MBBS, PGCert, et al.
Published: (2025-09-01)

Safety profiles of intravesical Bacillus Calmette-Guerin in bladder cancer
by: Yun Peng, et al.
Published: (2024-12-01)

Disseminated Granulomatous Disease from Intravesical Instillation of Bacillus Calmette-Guerin
by: Sayed Ab. Reshad Ghafouri, et al.
Published: (2018-01-01)

Effectiveness of the Bacillus Calmette-Guerin vaccine in an Indonesian population with D543N NRAMP1 polymorphism
by: Ikhwanuliman Putera, et al.
Published: (2015-01-01)

The Emerging Treatment of BCG (Bacillus Calmette-Guérin)-Unresponsive Non–Muscle-Invasive Bladder Cancer
by: Jong Ho Park, et al.
Published: (2024-11-01)

Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin
by: Caterina Giovanna Valentini, et al.
Published: (2012-01-01)

Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin
by: Caterina Giovanna Valentini, et al.
Published: (2012-06-01)

Effect of Bacillus Calmette-Guérin vaccination against Mycobacterium tuberculosis infection in children: an updated systematic review and meta-analysis
by: Shunli Cai, et al.
Published: (2025-07-01)

Factors influencing the efficacy of Bacille Calmette-Guérin (BCG) vaccine
by: Lwandile Bukula, et al.
Published: (2025-03-01)

<i>Bacillus Calmette–Guérin</i> Vaccination Promotes Efficient and Comprehensive Immune Modulation in Guinea Pig Models
by: In-Ohk Ouh, et al.
Published: (2025-03-01)

Long-term outcome of Bacillus Calmette-Gue’rin instillation therapy for the upper urinary tract carcinoma in situ
by: Kota Iida, et al.
Published: (2025-06-01)

The Impact of Bacillus Calmette–Guérin Vaccination and <i>Mycobacterium bovis</i> Infection on Diagnostic Antibody Tests for Mycobacterial Infections
by: Thomas Holder, et al.
Published: (2025-05-01)

Rates and Risk Factors of Bacteriuria in Patients with Bladder Cancer Who Underwent Treatment with Bacillus Calmette-Guérin
by: Seong Jong Eun, et al.
Published: (2020-08-01)

The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines.
by: Paola Villanueva, et al.
Published: (2022-01-01)

FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer
by: Yang Zhang, et al.
Published: (2022-03-01)

Patient-Reported Urinary Symptom Progression After Bacillus Calmette–Guerin Therapy for Bladder Cancer
by: Zorawar Singh, et al.
Published: (2025-02-01)

Afebrile tuberculous prostatic abscess with rectal fistula after intravesical Bacillus Calmette‐Guérin immunotherapy
by: Tatsuhiro Sawada, et al.
Published: (2025-01-01)

Peripheral Mechanisms Underlying Bacillus Calmette–Guerin-Induced Lower Urinary Tract Symptoms (LUTS)
by: Meera Elmasri, et al.
Published: (2024-11-01)

Training the synergy between Bacillus Calmette‐Guérin and immune checkpoint‐blocking antibodies in bladder cancer
by: Renate Pichler, et al.
Published: (2025-04-01)

Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells.
by: Manjunatha M Venkataswamy, et al.
Published: (2014-01-01)

Scar among Bacillus Calmette-Guérin Vaccinated Children Presenting to an Immunisation Clinic at a Tertiary Hospital in Nepal: An Observational Study
by: Ajaya Kumar Dhakal, et al.
Published: (2025-04-01)

Effects of Bacillus Calmette-Guérin (BCG Moscow) vaccination on white blood cell count: results of a randomized clinical trial
by: Amanda da Rocha Oliveira Cardoso, et al.
Published: (2025-04-01)

Bacille Calmette–Guerin Vaccine May Be an Effective Tool for COVID-19 Prevention
by: Vinod P. Jerath, et al.
Published: (2024-01-01)

Central Nervous System Infections Caused by Bacillus Calmette–Guerin: Case Report and Narrative Literature Review
by: Davide Chemello, et al.
Published: (2025-05-01)

Bacillus Calmette-Guerin (BCG) infections following intravesical BCG immunotherapy: a systematic review protocol
by: Roberta Monardo, et al.
Published: (2025-01-01)

The role of Uro-Vaxom in reducing infectious adverse effects and improving outcomes in bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer
by: Sookyung Cho, et al.
Published: (2025-07-01)

Successful Treatment of Disseminated Bacillus Calmette-Guérin Disease in an HIV-Infected Child with a Linezolid-Containing Regimen
by: Srđan Roglić, et al.
Published: (2016-01-01)

Oral delivery of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in alginate spheres to captive white-tailed deer
by: Paola M. Boggiatto, et al.
Published: (2025-03-01)

The Lack of Association Between Bacille Calmette-Guerin Vaccination and Clustering of Aboriginals with Tuberculosis in Western Canada
by: Victoria J Cook, et al.
Published: (2005-01-01)

An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19.
by: Lucy Chimoyi, et al.
Published: (2020-01-01)

Unmasking Bacillus Calmette–Guérin Immune Reconstitution Inflammatory Syndrome in a Perinatal HIV Transmission—A Case Report
by: Daniel Ivanov, et al.
Published: (2025-05-01)

The effect of intravesical Bacillus Calmette-Guerin (BCG) treatment on sperm parameters in non-muscle-invasive bladder cancer patients
by: Sergen Sahin, et al.
Published: (2025-05-01)

Efficacy of intravesical gemcitabine instillation compared with intravesical Bacillus Calmette-Guérin instillation for non-muscle invasive bladder cancer
by: Dong Ha Kim, et al.
Published: (2024-12-01)

Altered Memory T-Cell Responses to Bacillus Calmette-Guerin and Tetanus Toxoid Vaccination and Altered Cytokine Responses to Polyclonal Stimulation in HIV-Exposed Uninfected Kenyan Infants.
by: Miguel A Garcia-Knight, et al.
Published: (2015-01-01)

Difference in recurrence frequencies of non-muscle-invasive-bladder tumors depending on optimal usage of intravesical immunotherapy of bacillus Calmette-Guérin
by: Milošević Radovan, et al.
Published: (2015-01-01)

The natural course of bacillus Calmette-Guérin induced bladder lesions: A long-term follow-up study and systematic review
by: Chong Ma, et al.
Published: (2023-07-01)